Biofrontera Inc. to Present at the LD Micro Main Event XV Investor Conference
October 20 2022 - 10:40AM
Biofrontera Inc. (Nasdaq:
BFRI), a biopharmaceutical company specializing in the
commercialization of dermatological products, announced today that
Erica Monaco, Chief Executive Officer, will be presenting and
meeting with registered investors at the LD Micro Main Event XV
that will be held October 25-27, 2022 at the Luxe Sunset Boulevard
Hotel in Southern California.
Event: |
LD Micro Main Event XV |
Date: |
Wednesday, October 26, 2022 |
Presentation Time: |
4:00 PM Pacific Time (7:00 PM Eastern Time) |
Location: |
Luxe Sunset Boulevard Hotel, Los Angeles, CA |
Webcast: |
https://me22.sequireevents.com |
A webcast of the presentation will be live and
archived on the News & Events section of the company website.
Institutional investors registered for the conference who would
like to meet with Erica Monaco and Hermann Lübbert, Executive
Chairman of Biofrontera Inc., please contact LD Micro directly or
the BFRI investor relations team.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based
biopharmaceutical company commercializing a portfolio of
pharmaceutical products for the treatment of dermatological
conditions with a focus on photodynamic therapy (PDT) and topical
antibiotics. The Company’s licensed products are used for the
treatment of actinic keratoses, which are pre-cancerous skin
lesions, as well as impetigo, a bacterial skin infection. For more
information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.Anke zur
Mühlen+1 781 486 1539us-ir@biofrontera.com
LHA Investor RelationsTirth T.
Patel+1 212 201 6614tpatel@lhai.com
# # #
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Sep 2024 to Oct 2024
Biofrontera (NASDAQ:BFRIW)
Historical Stock Chart
From Oct 2023 to Oct 2024